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“Alchemy: a process of transforming something common into something 
special”—Webster’s Dictionary
A 
growing number of studies are reporting the 
isolation of cardiac stem cells from a variety of tissue 
sources and examining their effects on promoting 
the repair of the injured heart. In the current issue of PLoS 
Biology, the storyline takes an unexpected, interesting twist, 
as Neal Epstein and his colleagues report the isolation of a 
novel cell type from skeletal muscle that can adopt a highly 
differentiated cardiac muscle cell phenotype in vitro and in 
vivo [1].
In this study, the authors use a differential isolation 
procedure to remove the skeletal muscle cells and myoblasts 
(immature muscle cells), and then collect the cells that 
are negative for a cell-surface marker called Sca-1. Under 
deﬁ  ned in vitro conditions, these cells adopt a cardiomyocyte 
phenotype that goes beyond the simple expression of cardiac-
restricted biochemical and molecular markers, extending 
to the types of single-cell physiological functions that are 
hallmarks of authentic cardiomyocytes, including action 
potentials, calcium transients, and contractile activity. They 
call the cells Spoc cells, an acronym for “skeletal-based 
precursor of cardiomyocytes.”
The study goes on to show that these cells can adopt this 
phenotype without the addition of cytokines or agents such 
as azacytidine that are known to activate the muscle gene 
program in nonmuscle cells. The cells also adopt the cardiac 
phenotype following their in vivo implantation into the 
ischemic heart following myocardial infarction, suggesting 
a potential therapeutic utility for these cells. Since Spoc 
cells were isolated from murine skeletal muscle, they may 
eventually allow the use of sophisticated conditional genetic 
tracking techniques to monitor the migration, maturation, 
and differentiation of the cells in the in vivo context.
Of course, a study with results this unexpected also raises 
a number of intriguing questions. Identifying the native 
location of Spoc cells, as well as the in vivo niche that 
insulates them from entering the differentiated cardiac 
program, will be valuable. A rigorous exploration of their 
developmental origin and their relationship to the other well-
known cell types in skeletal muscle should be forthcoming. In 
this regard, a set of skeletal muscle stem cells, distinct from 
myoblasts, has also been found [2], and the question arises 
as to whether Spoc cells are related to these other skeletal 
muscle progenitors. 
Cardiomyocyte Precursors Abound
Other studies have reported the isolation of cells that can 
differentiate into cardiac muscle from diverse noncardiac 
tissues. In vitro and in vivo studies have suggested that 
these cells can adopt deﬁ  ned features of the cardiomyocyte 
phenotype when they are implanted into injured heart 
following myocardial infarction. It is possible that these 
studies are pointing to the existence of a rare circulating pool 
of precursor cells, which are able to home to the heart. 
To understand the provenance of these cells, it will become 
critical to identify a set of gene products, or markers, that 
are restricted to Spoc cells and to other potential progenitor 
cells. Since the protocols for the isolation of the Spoc cells 
have been developed in the mouse, it should also become 
possible to use state-of-the-art spatial and temporal control 
strategies for triggering irreversible lineage tracers in these 
cells in the in vivo context without isolating the cells per se. 
This will make it possible to follow the fate of these cells as 
they differentiate. Similar approaches have recently been 
used to identify a subset of rare, native cardiac progenitors 
(which are positive for the marker Islet-1) in the newborn 
hearts of mice, rats, and humans (Figure 1; [3]). Exploring 
the relationship of the Spoc cells to these native cardioblasts 
could reveal shared pathways that drive their formation, 
renewal, and differentiation.
Deﬁ  ning a True Progenitor
One of the inherent caveats of the present study is the 
potential for phenotypic drift that occurs with prolonged 
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Figure 1. Islet-1-Positive Cardioblast in the Right Ventricular Chamber of 
the Neonatal Rat Heart
Islet-1 nuclear staining depicted in green, nuclear staining in 
blue, myocyte marker staining in red. The left panel shows 
triple staining; the right panel shows single staining for Islet-1 
expression.PLoS Biology  |  www.plosbiology.org 0570
growth of any cell type. It is possible, for example, that the 
genetic program of these cells gradually changes with time 
such that they can more easily adopt the cardiac phenotype. 
Heart and skeletal muscle share many key gene regulatory 
factors and downstream genetic programs, and the loss of 
a few key negative regulatory checkpoints might allow the 
cells to differentiate towards a cardiac phenotype. Again, 
documenting the existence of these cells in the in vivo 
context, particularly during stages of embryonic myogenesis, 
will be key. 
There is already a clear precedent for this type of 
phenotypic drift between cardiac and skeletal muscle. H9c2 
cells were originally derived from rat heart, but actually 
represent skeletal myoblasts, because they fuse and form 
myotubes following serum withdrawal. These cells express 
myogenic factors in the MyoD family, and do not express 
cardiac-restricted factors. Although the cells were initially 
isolated on the basis of their expression of cardiac markers, 
this is an example phenotypic drift—that is, the cells have 
drifted from a cardiac phenotype during repeated passage 
rather than simply representing skeletal muscle cells resident 
within the heart. Thus, the isolation of an immature cell 
from a heart does not necessarily denote that it is serving as 
a cardiac progenitor or stem cell. Potentially the same issue 
might hold for putative cardiac progenitor cells isolated 
from skeletal muscle, where the phenotype observed may not 
necessarily reﬂ  ect  its role in vivo within skeletal muscle.
One of the difﬁ  culties with alchemy and this new age of 
cardiac myocyte biology is related to deﬁ  ning a rigorous set 
of criteria that allow one to make the claim that the cell type 
of interest is truly a cardiac progenitor or stem cell and is 
acquiring a fully differentiated phenotype [4]. In this regard, 
the paper by Epstein and colleagues has done an admirable 
job of scoring for functional phenotypes (for example, having 
action potentials and calcium transients) that are far beyond 
the simple expression of cardiac muscle markers, which has 
been the phenotypic endpoint for many previous papers in the 
ﬁ  eld. In addition, the authors go on to show the acquisition of 
the differentiated cardiac phenotype in the in vivo state in the 
absence of fusion with neighboring cardiac muscle cells, which 
has been a confounding variable in most other studies of this 
type. If a precursor cell simply fuses with a fully differentiated 
cell in a tissue, one could easily be fooled into thinking that 
the precursor has itself differentiated, as has been found for 
many types of putative cardiac stem cells [5]. Fortunately, 
techniques have been devised to detect such events.
In surveying the growing number of studies and claims of 
new cells that can acquire some type of heart cell phenotype 
in vitro or in vivo (for a review see [6]), it will become 
increasingly important to create a set of rigorous criteria 
that would distinguish between the following: authentic 
progenitor cells that are already committed to the cardiac 
lineage; pluripotent stem cells that can infrequently adopt 
the cardiac phenotype; phenotypic drift of other muscle 
progenitors with an increased propensity to enter cardiac 
lineages; and a variety of other cell types that can aberrantly 
express cardiac markers ectopically or by fusion with 
neighboring cardiac muscle cells. 
Finding cell-type-speciﬁ  c markers for these cells will be 
critical, as opposed to generalized markers that do not 
allow the in vivo discrimination of their precise localization, 
mobilization, and differentiation in the intact muscle. The 
gold standard would then become the isolation of the cells 
from the intact organ after differentiation has occurred by 
creating genetically based or antibody-based approaches to 
identify and/or purify the already differentiated progeny 
from the intact muscle. Alternatively, new two-photon 
confocal microscopy approaches to identify the cells and then 
to monitor cardiac function in the intact heart should prove 
valuable [7]. 
For two decades, the bulk of our knowledge of molecular 
pathways that guide cardiac growth, development, and disease 
has been gleaned from a combination of in vivo studies in 
genetically engineered mice and primary cultures of neonatal 
and adult rat cardiomyocytes. Perhaps the most scientiﬁ  cally 
exciting aspect of this new age of cardiomyocyte biology is 
not simply related to cardiac repair. To date, there have been 
no continuous differentiated cardiac cell lines, a fact that 
has hampered the ﬁ  eld for decades. The development of 
well-characterized cardiac progenitor cells offers the promise 
of using real genetic-based approaches to rapidly deﬁ  ne the 
complex pathways that guide cardiac contractility, excitability, 
and lineage diversiﬁ  cation into atrial, ventricular, and 
conduction system myocyte cell lineages.  
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